DOI QR코드

DOI QR Code

Comparative Study of the Neuroprotective Effect of Sihogyeji-tang, Sihosogan-tang, and Sihocheonggan-tang on an MPTP-Induced Parkinson's Disease Mouse Model

MPTP로 유도된 파킨슨병 생쥐 모델에 대한 시호계지탕, 시호소간탕, 시호청간탕의 신경세포 보호 효과 비교 연구

  • Ji Eun Seo (Department of Korean Medical Science, School of Korean Medicine, Pusan National University) ;
  • Hanul Lee (Korean Medicine Research Center for Healthy Aging, Pusan National University) ;
  • Chang-Hwan Bae (Department of Korean Medical Science, School of Korean Medicine, Pusan National University) ;
  • Dong Hak Yoon (KyungHee YDH Oriental Clinic) ;
  • Hee-Young Kim (Korean Medicine Research Center for Healthy Aging, Pusan National University) ;
  • Seungtae Kim (Department of Korean Medical Science, School of Korean Medicine, Pusan National University)
  • 서지은 (부산대학교 한의학전문대학원 한의과학과) ;
  • 이한울 (부산대학교 건강노화한의과학연구센터) ;
  • 배창환 (부산대학교 한의학전문대학원 한의과학과) ;
  • 윤동학 (경희윤동학한의원) ;
  • 김희영 (부산대학교 건강노화한의과학연구센터) ;
  • 김승태 (부산대학교 한의학전문대학원 한의과학과)
  • Received : 2023.06.29
  • Accepted : 2023.08.12
  • Published : 2023.09.27

Abstract

Objectives : Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide and is characterized by the loss of the dopaminergic neurons in the substantia nigra (SN). In a previous in vitro study, we demonstrated that Sihogyeji-tang (SG), Sihosogan-tang (SS), and Sihocheonggan-tang (SC) have the potential to be candidate medicines for PD. This study aimed to compare the neuroprotective effect of SG, SS, and SC using 1-methyl-4-phenyl-1,2,3,6-tetrahydrophridine (MPTP)-induced PD mouse model. Methods : Eight-week-old male C57BL/6 mice were intraperitoneally administered with 30 mg/kg of MPTP for 5 days and orally administered SG, SS and SC for 12 days from the first MPTP injection. Motor function was assessed using the pole test and the rotarod test. Dopaminergic neuronal survival in the SN and striatum was evaluated through tyrosine-hydroxylase immunohistochemistry. Results : MPTP administration resulted in behavioral impairment and dopaminergic neuronal death in the SN and striatum. In the pole test, treatment with SG, SS, and SC alleviated the MPTP-induced motor dysfunction on day 5 and 12. In the rotarod test, SS and SG alleviated the MPTP-induced motor dysfunction on day 5, while only SS showed improvement on day 12. SS and SG significantly protected dopaminergic neurons in the SN from MPTP toxicity, and all three compounds (SG, SS, and SC) showed significant protection in the striatum. Notably, SS demonstrated superior efficacy in suppressing MPTP-induced motor dysfunction and dopaminergic neuronal death compared to SG and SC. Conclusions : These findings suggest that SS is the most effective formula among SG, SS, and SC for PD, indicating its potential role in the treatment of PD.

Keywords

Acknowledgement

This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Instiute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HF21C0053).

References

  1. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003 ; 39(6) : 889-909. https://doi.org/10. 1016/s0896-6273(03)00568-3 https://doi.org/10.1016/s0896-6273(03)00568-3
  2. Luquin MR, Kulisevsky J, Martinez-Martin P, Mir P, Tolosa ES. Consensus on the definition of advanced Parkinson's disease: A neurologists-based delphi study (CEPA study). Parkinsons Dis. 2017 ; 2017 : 4047392. https://doi.org/10.1155/2017/4047392
  3. Lee JE, Choi J, Lim HS, Kim JH, Cho JH, Kim GS, et al. The prevalence and incidence of Parkinson' s disease in South Korea: A 10-year nationwide population-based study. J Korean Neurol Assoc. 2017 ; 35(4) : 191-8. https://doi.org/10.17340/jkna.2017.4.1
  4. Breydo L, Wu JW, Uversky VN. α-Synuclein misfolding and Parkinson's disease. Biochim Biophys Acta. 2012 ; 1822(2) : 261-85. https://doi.org/10.1016/j.bbadis.2011.10.002
  5. Dodson MW, Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol. 2007 ; 17(3) : 331-7. https://doi.org/10.1016/j.conb.2007.04.010
  6. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology. 2001 ; 56(11 Suppl 5) : S1-88. https://doi.org/10.1212/wnl.56.suppl_5.s1
  7. Seo JE, Lee H, Bae CH, Yoon DH, Kim HY, Kim S. Comparative study of 12 herbal formulae covered by the national health insurance service in Korea. Korean J Acupunct. 2022 ; 39(2) : 34-42. https://doi.org/10.14406/acu.2022.006
  8. Lee SH, Heo YJ, Cho YS. 4 cases of chronic abdominal pain children treated by Sihogyeji-tanggagam with acupuncture and moxibustion treatment. JPPKM. 2021 ; 35(6) : 261-6. https://doi.org/10.15188/kjopp.2021.12.35.6.261
  9. Ko SJ, Kim JS, Park JW, Ha NY. Korean medicine clinical practice guideline for functional dyspepsia. 1st ed. Gyeongsan : Division of clinical practice guideline of Korean medicine in National Institute for Korean Medicine Development. 2021 : 100. Available from: URL:https://nikom.or.kr/nckm/module/practiceGuide/view.do?guide_idx=192&menu_idx=14
  10. An JH, Hwang ML, Yoon HJ, Jung HA. A Review on the Sihocheonggan-tang & Sihocheonggan-san for the treatablity of atopic dermatitis. The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology. 2017 ; 30(1) : 10-6. https://doi.org/10.6114/JKOOD.2017.30.1.010
  11. Kim BR, Huh K, Lim SW. Effect of Sihogeji-tang extract on indomethacin-Induced Gastric mucosal Lesions in Rats. Korean J Orient Int Med. 2010 ; 31(3) : 477-87.
  12. Sun Y, Xu X, Zhang J, Chen Y. Treatment of depression with Chai Hu Shu Gan San: A systematic review and meta-analysis of 42 randomized controlled trials. BMC Complement Altern Med. 2018 ; 18(1) : 66. https://doi.org/10.1186/s12906-018-2130-z
  13. Li Z, Zeng Q, Hu S, Liu Z, Wang S, Jin Y, et al. Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8. Front Pharmacol. 2023 ; 14 : 1181226. https://doi.org/10.3389/fphar.2023.1181226
  14. Food and Drug Administration. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville : U.S. Food and Drug Administration. 2005 : 6-9. Available from: URL:https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers
  15. Buettner GR. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem. 2011 ; 11(4) : 341-6. https://doi.org/10.2174/1871520 11795677544
  16. Abe K, Taguchi K, Wasai T, Ren J, Utsunomia I, Shinohara T, et al. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse. Brain Res. 2001 ; 907(1-2) : 134-8. https://doi.org/10.1016/s0006-8993(01)02573-2
  17. Park G, Park YJ, Yang HO, Oh MS. Ropinirole protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism. Pharmacol Biochem Behav. 2013 ; 104 : 163-8. https://doi.org/10.1016/j.pbb.2013.01.017
  18. Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, et al. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res. 2007 ; 1131(1) : 211-9. https://doi.org/10.1016/j.brainres.2006.10.089
  19. Kum WF, Durairajan SSK, Bian ZX, Man SC, Lam YC, Xie LX, et al. Treatment of idiopathic Parkinson's disease with traditional Chinese herbal medicine: a randomized placebo-controlled pilot clinical study. Evid Based Complement Alternat Med. 2011 ; 2011 : 724353. https://doi.org/10.1093/ecam/nep116
  20. Elyasi L, Ghazvini H. The protective effects of Citrus aurantium extract on a 6-Hydroxydopamine-induced model of Parkinson's disease in male rats. Anatomical Sciences. 2020 ; 17(1) : 1-6.
  21. Lee CH, Hwang DS, Kim HG, Oh H, Park H, Cho JH, et al. Protective effect of Cyperi rhizoma against 6-hydroxydopamine-induced neuronal damage. J Med Food. 2010 ; 13(3) : 564-71. https://doi.org/10.1089/jmf.2009.1252